Related Experiment Video

Updated: Jun 14, 2025

Methodology for Sputum Induction and Laboratory Processing
13:28

Methodology for Sputum Induction and Laboratory Processing

Published on: December 17, 2017

27.5K

Comparison and review of international guidelines for treating asthma in children

Eui Jeong Roh1

  • 1Department of Pediatrics, Chungnam National University Hospital, Daejeon, Korea.

Clinical and Experimental Pediatrics
|September 3, 2024
PubMed

Insights

Pediatric asthma treatment guidelines vary globally, causing confusion for clinicians. This review compares recent international drug therapy recommendations to inform future childhood asthma care guidelines.

Area of Science:

  • Pediatric Pulmonology
  • Allergy and Immunology
  • Public Health

Background:

  • Asthma is a prevalent chronic respiratory disease affecting 300 million worldwide, with 30% being children.
  • Pediatric asthma significantly contributes to morbidity, including hospitalizations and mortality in severe cases.
  • Current international asthma guidelines offer differing drug therapy recommendations, leading to clinical confusion.

Purpose of the Study:

  • To investigate recent changes in global pediatric asthma guidelines.
  • To compare and analyze international drug therapy recommendations for childhood asthma.
  • To identify global trends in pediatric asthma pharmacotherapy.

Main Methods:

  • Systematic review of major international asthma guidelines.
  • Comparative analysis of drug therapy recommendations for pediatric patients.
  • Identification of recent revisions and shifts in guideline content.

Main Results:

  • Significant recent updates observed across multiple international pediatric asthma guidelines.
  • Discrepancies in recommended drug classes and treatment approaches were identified.
  • Emerging trends indicate a move towards specific therapeutic strategies in pediatric asthma management.

Conclusions:

  • International pediatric asthma guidelines present varied drug therapy recommendations.
  • A comprehensive comparison is crucial for harmonizing treatment approaches.
  • Findings can guide the development of future, evidence-based Korean guidelines for childhood asthma.

Keywords:
AsthmaChildGuidelineTreatment

More Related Videos

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus06:15

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus

Published on: March 6, 2019

49.7K
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

31.9K

Related Concept Videos

Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
228
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
251
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.5K